poisar

Stocks · News reference

Wix.com shares are trading higher after Wedbush raised its price target on the stock from $55 to $80.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncKahn Swick & Foti, Llc

    Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

    Kahn Swick & Foti, LLC announces a class action securities lawsuit against Wix.com Ltd. for investors who purchased shares between February 19, 2025 and May 12, 2026. The lawsuit alleges that Wix and its executives failed to disclose material information, including overstating AI product competitiveness and performance while understating development costs, resulting in materially false and misleading public statements. The deadline to request lead plaintiff status is September 22, 2026.

  2. Globenewswire IncKaplan Fox & Kilsheimer Llp

    Kaplan Fox Encourages Wix.com Ltd. (NASDAQ: WIX) Investors with Significant Losses to Contact the Firm Before September 22, 2026

    Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against Wix.com, Hertz Global Holdings, and Hims & Hers Health on behalf of investors who suffered losses. The Wix lawsuit covers investors from February 19, 2025 to May 12, 2026, alleging the company misrepresented its AI capabilities while costs accelerated. Wix's stock fell 27.1% following disappointing Q1 2026 results. Investors with losses are encouraged to contact the firm before respective deadlines.

  3. Zacks Investment ResearchNa

    Why Is Wix.com (WIX) Up 34.3% Since Last Earnings Report?

    Wix.com reported Q2 2026 earnings of $1.39 per share, beating consensus estimates of $1.13, with revenues rising 15% year-over-year to $563.1 million. The company's AI-powered Base44 product drove strong performance across Creative Subscriptions and Business Solutions segments. However, elevated AI spending pressured gross margins, which declined to 67% from 70% year-over-year. Management expects margin improvement in H2 2026 as Base44's cost structure optimizes. The stock has gained 34.3% in the past month but carries a Zacks Rank #3 (Hold) rating with a D VGM Score.